Shanghai YaKe Biotechnology Co., Ltd.
PrivateLast Round
Series A
May 1, 2016
Total Funding Raised
$1.53M
Company Overview
Shanghai YaKe Biotechnology Co., Ltd. is a biotechnology company that develops cancer immunotherapy technologies, specifically focusing on CAR-T cell therapies for B-cell malignancies and other blood cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai YaKe Biotechnology Co., Ltd. Comparables
Compare Shanghai YaKe Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PersonGen BioTherapeutics | 89% | |
| Shanghai Unicar-Therapy Bio-medicine Technology | 88% | |
| Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. | 87% | |
Shanghai YaKe Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 1, 2016 |
Shanghai YaKe Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai YaKe Biotechnology Co., Ltd.'s valuation, stock price, and market status.